Confirmation

A focused and interdisciplinary evaluation of a patient's cancer case by a panel of experts in genetics oncology and related fields aiming to tailor personalized treatment strategies based on the unique genetic and molecular characteristics of the tumor ultimately improving treatment outcomes.

A concise and authoritative suggestion from a medical review board or panel of experts guiding healthcare professionals on the appropriate medications to prescribe for specific medical conditions ensuring evidence-based and optimal treatment decisions.

Numerical score used to identify regions in the genome where an individual has lost one copy of a specific gene or allele often associated with genetic disorders and cancer research.

An expert-endorsed suggestion advising individuals to consider participation in a specific research study or clinical trial often based on their medical condition or relevant criteria aiming to contribute to scientific advancements and personalized healthcare.

Cancer treatment response monitoring by imaging techniques to assess and track the effectiveness of cancer therapies and their impact on tumor size and progression.

Systematic tracking and assessment of an individual's or population's intake of alcoholic beverages typically for health safety or research purposes.

The PD-L1 IHC (Programmed Death-Ligand 1 Immunohistochemical) test is a diagnostic assay utilized in oncology to assess the expression of PD-L1 protein in tissue samples aiding in treatment decisions particularly for immunotherapy in cancer patients.